710-1271

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2012-09-27

AEs

Serious

Dropout signal

–

Adverse events

moderate assessed

Moderate ATRIAL FIBRILLATION — outcome: RECOVERED/RESOLVED; onset 2012-11-21 (study day 56.0); relationship: POSSIBLE; serious criteria: hospitalization, life-threatening

moderate assessed

Moderate CARDIAC FAILURE CONGESTIVE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-11-22 (study day 57.0); relationship: POSSIBLE; serious criteria: hospitalization, life-threatening

moderate assessed

Moderate DYSPNOEA — outcome: RECOVERED/RESOLVED; onset 2012-11-21 (study day 56.0); relationship: POSSIBLE; serious criteria: hospitalization

moderate assessed

Moderate HYPONATRAEMIA — outcome: RECOVERED/RESOLVED; onset 2012-11-22 (study day 57.0); relationship: REMOTE; serious criteria: hospitalization

severe assessed

Severe MYOCARDIAL INFARCTION — outcome: RECOVERED/RESOLVED; onset 2012-11-21 (study day 56.0); relationship: POSSIBLE; serious criteria: hospitalization, life-threatening

Data queries

No data queries.